SCHEMBL987625

SCHEMBL987625

OCOCOCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.61
KDM4E B2RXH2 1/20 0.50
POLB P06746 1/20 0.50
CA1 P00915 5/20 0.46
CA2 P00918 3/20 0.46
CA9 Q16790 3/20 0.46
CA7 P43166 2/20 0.46
IDO1 P14902 1/20 0.44
AGXT P21549 1/20 0.43
ALDH1A1 P00352 3/20 0.42
SLC6A2 P23975 2/20 0.42
SLC6A3 Q01959 2/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
PTGS1 P23219 1/20 0.42
CYP2C19 P33261 1/20 0.42
PTGS2 P35354 1/20 0.42
HIF1A Q16665 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
TDP1 Q9NUW8 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methenamine SCHEMBL15021042 0.89 TSHR (0.48) TSHRKDM4EPOLBCA1CA2
SCHEMBL98298 0.88 TSHR (0.70) TSHRKDM4EPOLBCA1CA2
SCHEMBL223907 0.88 TSHR (0.78) TSHRKDM4EPOLBCA1CA2
SCHEMBL70291 0.85 TSHR (0.74) TSHRKDM4EPOLBCA1CA2
SCHEMBL53267 0.85 TSHR (0.74) TSHRKDM4EPOLBCA1CA2
Potassium Ion SCHEMBL28590044 0.84 TSHR (0.64) TSHRKDM4EPOLBCA1CA2
SCHEMBL10422277 0.82 TSHR (0.61) TSHRKDM4EPOLBCA1CA2
Hydrogen Peroxide SCHEMBL28758135 0.80 TSHR (0.94) TSHRKDM4EPOLBCA1CA2
SCHEMBL2593520 0.79 TSHR (0.52) TSHRKDM4EPOLBCA1CA2
Ethylene Glycol SCHEMBL130292 0.78 TSHR (0.79) TSHRKDM4EPOLBCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260041095-A1 A PRESERVATION METHOD ANALYTICON DISCOVERY ZWEIGNIEDERLASSUNG DER BRAIN BIOTECH AG (DE) 2026-02-12 US claimed
US-20260034044-A1 A PRESERVATIVE COMPOSITION ANALYTICON DISCOVERY ZWEIGNIEDERLASSUNG DER BRAIN BIOTECH AG (DE) 2026-02-05 US claimed
EP-4565197-A1 A PRESERVATIVE COMPOSITION AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4565065-A1 A PRESERVATION METHOD AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4565196-A1 A PRESERVATIVE COMPOSITION AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4450128-A2 ANTIMICROBIAL COMPOSITIONS Symrise AG (DE) 2024-10-23 EP claimed
US-20240058243-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES SYMRISE AG (DE) 2024-02-22 US claimed
WO-2024028267-A1 A PRESERVATIVE COMPOSITION BRAIN Biotech AG (DE) 2024-02-08 WO claimed
WO-2024028266-A1 A PRESERVATIVE COMPOSITION BRAIN Biotech AG (DE) 2024-02-08 WO claimed
WO-2024028265-A1 A PRESERVATION METHOD BRAIN Biotech AG (DE) 2024-02-08 WO claimed
EP-4316461-A1 A PRESERVATIVE COMPOSITION BRAIN Biotech AG (DE) 2024-02-07 EP claimed
EP-4316459-A1 A PRESERVATIVE COMPOSITION BRAIN Biotech AG (DE) 2024-02-07 EP claimed
EP-4259287-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES Symrise AG (DE) 2023-10-18 EP claimed
CN-116120396-A Polypeptide and application thereof in preparation of preservative 华南协同创新研究院 2023-05-16 CN claimed
WO-2022122144-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES SYMRISE AG (DE) 2022-06-16 WO claimed
EP-1898952-B1 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF WITH TROPOLONE SYMRISE AG (DE) 2012-09-12 EP claimed
EP-1898952-A2 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF AND TROPOLONE (DERIVATIVES) Symrise GmbH & Co. KG (DE) 2008-03-19 EP claimed
US-20070054967-A1 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF AND TROPOLONE (DERIVATIVES) SYMRISE GMBH & CO. KG (DE) 2007-03-08 US claimed
WO-2006134160-A2 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF AND TROPOLONE (DERIVATIVES) SYMRISE GMBH & CO. KG (DE) 2006-12-21 WO claimed
WO-1999008527-A1 COMPOSITIONS FOR TREATING TEXTILE AND PLASTIC ANTIMICROBIAL FINISH, AND USE OF SAME SANITIZED AG (CH) 1999-02-25 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260041095-A1 A PRESERVATION METHOD LSS, ASAH2, CUTA TSHR 3361/4885KDM4E 4437/4885POLB 1354/4885
US-20240058243-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES MGLL, GCDH, GK TSHR 3744/4885KDM4E 386/4885POLB 1329/4885
US-20070054967-A1 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF AND TROPOLONE (DERIVATIVES) NR1H3, NR1H2, CBR3 TSHR 494/4885KDM4E 2775/4885POLB 795/4885
US-20260034044-A1 A PRESERVATIVE COMPOSITION ERG28, FOXO3, DEGS1 TSHR 1111/4885KDM4E 4700/4885POLB 1187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.